Ali Behbahani, Director at Adaptimmune Therapeutics PLC (ADAP), sold 34,171,794 shares at $0.01 ($342K) on 2025-08-18, disclosed to the SEC on 2025-08-19.
Open-market sale of $342k ADAP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.01 | 4,828,206 | $48K | 14.1% |
| 2 | $0.01 | 14,671,794 | $147K | 42.9% |
| 3 | $0.01 | 14,671,794 | $147K | 42.9% |
| Total | $0.01 avg | 34,171,794 | $342K | 100% |
| Filing → |
| MBX | BUY | 2024-09-17 | $8.0M | — | Filing → |
| SVRA | BUY | 2023-07-19 | $1000K | — | Filing → |
| BDTX | BUY | 2023-07-06 | $5.0M | — | Filing → |